Abstract
Jurkat T leukemic cells respond to Etoposide, antineoplastic agent which targets the DNA unwinding enzyme, Topoisomerase II, and TNF-Related-Apoptosis-Inducing-Ligand (TRAIL), 34 kDa transmembrane protein, which displays minimal or no toxicity on normal cells and tissues, not only disclosing the occurrence of apoptosis but also a kind of resistance. A similar rate of viability upon the exposure to these two drugs up to 24 h has been evidenced, followed by the occurrence of a rescue process against TRAIL, not performed against Etoposide, along with an higher number of dead cells upon Etoposide exposure, in comparison with TRAIL treatment. These preliminary results let us to speculate on the possible involvement of PI-3-kinase in TRAIL resistance disclosed by surviving cells (20%), may be phosphorylating Akt-1 and, in parallel, IkappaB alpha on both serine and tyrosine residues. On the other hand, in Etoposide Jurkat exposed cells Ser 32-36 phosphorylation of IkappaB alpha is not sufficient to overbalance the apoptotic fate of the cells, since Bax increase, IAP decrease, and caspase-3 activation determine the persistence of the apoptotic state along with the occurrence of cell death by necrosis. Thus, the existence of a balance b...Continue Reading
References
Sep 15, 1995·The Journal of Biological Chemistry·S J Froelich-Ammon, N Osheroff
Jan 1, 1994·Annual Review of Pharmacology and Toxicology·A Y Chen, L F Liu
Aug 7, 1997·Nature·J A DiDonatoM Karin
Oct 29, 1998·The Journal of Biological Chemistry·D Wang, A S Baldwin
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·C BéraudP A Baeuerle
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K R Hande
Feb 4, 1999·Nature Medicine·H WalczakD H Lynch
Sep 15, 1999·Nature·O N OzesD B Donner
Apr 14, 2000·Leukemia·D M O'GormanT G Cotter
Aug 8, 2001·Leukemia Research·D M O'GormanT G Cotter
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Masayuki FujinoSeiichi Suzuki
Mar 21, 2003·Leukemia·F ChangJ A McCubrey
Apr 23, 2003·Cancer Letters·Young-Ju JangHyung-Il Kim
Jun 6, 2003·Cytokine & Growth Factor Reviews·Alexandru Almasan, Avi Ashkenazi
Jun 17, 2003·Journal of Neurochemistry·Daniela MilaniPaola Secchiero
Jun 26, 2003·British Journal of Haematology·Amalia Mouzakiti, Graham Packham
Oct 24, 2003·Leukemia·M C TurcoS Venuta
Citations
Aug 5, 2015·Clinical Oral Investigations·Silvia SancilioViviana di Giacomo
Dec 6, 2005·Molecular Carcinogenesis·Yongliang ZhaoTom K Hei
Apr 16, 2005·Journal of Cellular Biochemistry·Nadia SabatiniAmelia Cataldi
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Johan GaraudeMartin Villalba
Nov 18, 2015·International Journal of Oncology·Chiara Di NisioRoberta Di Pietro